Kimberly Walter

518 total citations
5 papers, 297 citations indexed

About

Kimberly Walter is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Cancer Research. According to data from OpenAlex, Kimberly Walter has authored 5 papers receiving a total of 297 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pulmonary and Respiratory Medicine, 2 papers in Genetics and 2 papers in Cancer Research. Recurrent topics in Kimberly Walter's work include Cancer Genomics and Diagnostics (2 papers), Lung Cancer Treatments and Mutations (2 papers) and Advanced Breast Cancer Therapies (1 paper). Kimberly Walter is often cited by papers focused on Cancer Genomics and Diagnostics (2 papers), Lung Cancer Treatments and Mutations (2 papers) and Advanced Breast Cancer Therapies (1 paper). Kimberly Walter collaborates with scholars based in United States and United Kingdom. Kimberly Walter's co-authors include Garret M. Hampton, Jill M. Spoerke, Mark R. Lackner, Junko Aimi, Steven Gendreau, Peter Schmid, Timothy R. Wilson, Lukas C. Amler, Stephen Johnston and Meng Chen and has published in prestigious journals such as Nature Communications, Cancer Research and Diabetes Technology & Therapeutics.

In The Last Decade

Kimberly Walter

5 papers receiving 289 citations

Peers

Countries citing papers authored by Kimberly Walter

Since Specialization

Citations

This map shows the geographic impact of Kimberly Walter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kimberly Walter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kimberly Walter more than expected).

Fields of papers citing papers by Kimberly Walter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kimberly Walter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kimberly Walter. The network helps show where Kimberly Walter may publish in the future.

Co-authorship network of co-authors of Kimberly Walter

This figure shows the co-authorship network connecting the top 25 collaborators of Kimberly Walter. A scholar is included among the top collaborators of Kimberly Walter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kimberly Walter. Kimberly Walter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

#	Work	Indexed citations
1	Activating Mutations in PIK3CB Confer Resistance to PI3K Inhibition and Define a Novel Oncogenic Role for p110β 2016 ·Cancer Research ·Yoshito Nakanishi, Kimberly Walter, Jill M. Spoerke, Carol O’Brien, Ling Huw, Garret M. Hampton, Mark R. Lackner	55
2	Heterogeneity and clinical significance of ESR1 mutations in ER-positive metastatic breast cancer patients receiving fulvestrant 2016 ·Nature Communications ·Jill M. Spoerke, Steven Gendreau, Kimberly Walter, Jiaheng Qiu, Timothy R. Wilson, Heidi Savage, Junko Aimi, Mika K. Derynck, Meng Chen, Iris T. Chan, Lukas C. Amler, Garret M. Hampton, Stephen Johnston, Ian E. Krop, Peter Schmid, Mark R. Lackner	219
3	Abstract PD6-03: High prevalence and clonal heterogeneity of ESR1 mutations (mt) in circulating tumor DNA (ctDNA) from patients (pts) enrolled in FERGI, a randomized phase II study testing pictilisib (GDC-0941) in combination with fulvestrant (F) in pts that failed a prior aromatase inhibitor (AI) 2016 ·Cancer Research ·(unknown), Steven Gendreau, Stephen Johnston, Peter Schmid, IE Krop, (unknown), Mika K. Derynck, Iris T. Chan, Kimberly Walter, Lukas C. Amler, Garret M. Hampton, Mark R. Lackner	2
4	Abstract 4978: Lung cancers regulate the immune suppressor PD-L1 by multiple mechanisms, altering its role in tumor survival. 2013 ·Cancer Research ·Edward E. Kadel, Kimberly Walter, Rupal Desai, Juliet G. Carbon, (unknown), David S. Shames, Marcin Kowanetz	1
5	"Waste Not, Want Not": Determining the Optimal Priming Volume for Intravenous Insulin Infusions 2006 ·Diabetes Technology & Therapeutics ·Philip A. Goldberg, Alexia T. Kedves, Kimberly Walter, (unknown), (unknown), Silvio E. Inzucchi	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact